Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism
- PMID: 7576100
- DOI: 10.1002/mc.2940140209
Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism
Abstract
In this study, we found that rat nasal coumarin-7-hydroxylase (COH) activity was two orders of magnitude higher than rat hepatic COH activity and could be induced by adding coumarin to the rats' drinking water. In western blot analysis, an anti-cytochrome P450 (Cyp) 2a-5 (mouse liver COH) antibody recognized a sharp band in the microsomal fraction of rat nasal epithelium but not of the liver; the band comigrated with Cyp2a-5. The intensity of the band was increased by the coumarin treatment. Similarly, in northern blot analysis, a cDNA probe specific for Cyp2a-5 recognized an mRNA in the nasal epithelium having the same size as mouse liver Cyp2a-5 mRNA; however, no hybridizable mRNA was recognized in liver preparations. Unlike the protein level, the level of the mRNA was not increased by coumarin. When northern blot analyses were performed with two oligoprobes specific for rat lung CYP2A3, an mRNA of similar size to Cyp2a-5 mRNA was recognized. In immunoinhibition analysis, anti-Cyp2a-5 antibody inhibited rat nasal COH activity and aflatoxin B1 (AFB1) metabolism completely. It inhibited N-nitrosodiethylamine (NDEA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism by 80-90%. In contrast, the hepatic metabolism of the four compounds was not affected by the antibody. When coumarin instead of anti-Cyp2a-5 antibody was used, a strong but variable inhibition of the nasal metabolism of AFB1, NDEA, and NNK was seen. The results suggest that an enzyme or enzymes similar to mouse liver Cyp2a-5, one of which may be CYP2A3, is expressed at high levels in rat nasal epithelium but not in the liver and that its expression is increased by coumarin, an odorant and a substrate of Cyp2a-5. The increase probably occurs by protein stabilization or stimulation of translation. The results also show that the enzyme has a key role in the nasal metabolism of three well-known carcinogens, AFB1, NDEA, and NNK and may therefore be an important contributing factor in nasal carcinogenesis.
Similar articles
-
High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans.Mol Carcinog. 1993;7(4):268-75. doi: 10.1002/mc.2940070410. Mol Carcinog. 1993. PMID: 8352885
-
Nasal cytochrome P450 2A: identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen.Toxicol Appl Pharmacol. 1997 Jan;142(1):22-30. doi: 10.1006/taap.1996.7975. Toxicol Appl Pharmacol. 1997. PMID: 9007030
-
Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis.Carcinogenesis. 2001 Nov;22(11):1877-83. doi: 10.1093/carcin/22.11.1877. Carcinogenesis. 2001. PMID: 11698352
-
CYP2A6: a human coumarin 7-hydroxylase.Toxicology. 2000 Apr 3;144(1-3):139-47. doi: 10.1016/s0300-483x(99)00200-0. Toxicology. 2000. PMID: 10781881 Review.
-
The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.Pharmacogenetics. 1995;5 Spec No:S123-8. doi: 10.1097/00008571-199512001-00013. Pharmacogenetics. 1995. PMID: 7581481 Review.
Cited by
-
Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis.ACS Omega. 2020 Mar 4;5(10):5334-5339. doi: 10.1021/acsomega.9b04357. eCollection 2020 Mar 17. ACS Omega. 2020. Retraction in: ACS Omega. 2021 Nov 19;6(48):33239. doi: 10.1021/acsomega.1c06159. PMID: 32201822 Free PMC article. Retracted.
-
Cell-specific expression of CYP2A5 in the mouse respiratory tract: effects of olfactory toxicants.J Histochem Cytochem. 2003 Nov;51(11):1545-55. doi: 10.1177/002215540305101114. J Histochem Cytochem. 2003. PMID: 14566026 Free PMC article.
-
Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver.Eur J Drug Metab Pharmacokinet. 2003 Jan-Mar;28(1):41-8. doi: 10.1007/BF03190865. Eur J Drug Metab Pharmacokinet. 2003. PMID: 14503663
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources